Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome. Research Abstract Details
Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome. Publishing Authors By Initials
Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome. Journal Published:
PUBLICATION TYPE: Letter
Journal: International journal of urology : official journa
VOLUME: 14
Page Numbers: 670; author reply 670-1
Journal Abbreviation: Int. J. Urol.
ISSN: 0919-8172
DAY: 24
MONTH: Jul
YEAR: 2007
Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9440237
Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
AFFILIATION:
Country: Australia
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Int J Urol
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome Related Publications